Thromboprophylaxis in medical in-patients: are we there yet?

M. Paracha, M. Javed, G. Bhat (Blackpool, Bolton, United Kingdom)

Source: Annual Congress 2007 - Venous thromboembolism
Session: Venous thromboembolism
Session type: Thematic Poster Session
Number: 629
Disease area: Pulmonary vascular diseases

Congress or journal article abstract

Abstract

Introduction: 10-20% of hospitalized medical patients develop DVT.In the UK alone, PE following DVT is estimated to causes 25-32,000 hospital deaths per year and is immediate cause in 10%1. Thromboprophylaxis with low dose heparin is effective in high risk patients not only to prevent fatal PE, but also symptomatic DVT/PE which prolong hospital stay and require further testing increasing cost.Subsequent need for warfain anticoagulation has its attendant risk of bleeding . Purpose of present study was to to determine whether thromboprophylaxis was being used in our institution according to established guidelines2.
Method: We reviewed notes and treatment of patients admitted to eight general medical wards over a 2 week period.Cardiology,Hematology/Oncology and Stroke wards were excluded.
Results: 150 patients were reviewed.Age range 31-96 ( Mean=73.9years).Thromboprophylaxis was indicated in 126/150 (84%).21 excluded due to contraindication for aniticoagulation.Of remaining 105 only 37 (35.2%) recieved prophylactic heparin.(See table)
Conclusion:Majority of acutely ill medical patients require thromboprophylaxis.However, despite clear guidelines thromboprophylaxis remains significanly suboptimal.
Referances:
1.2nd report of UK Health Select Committe 23 Feb 2005
2.CHEST 2004; 126:338S–400S.

No.given thromboprophylaxis according to risk factors
RISK FACTORNo.No. given prophylaxis
Age moreñ708222(27%)
Acute Heart Failure124(33%)
Active Cancer92(22%)
Severe Infection73 (42%)
Previous DVT/PE21(50%)
History of Malignancy127(58%)
Ischeamic Stroke51(20%)
Immobilityñ48 hours346(17%)
Paraplegia10
Severe Respiratory Disease174 (23%)
Total 181 as some patients had more than one risk factor




Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Paracha, M. Javed, G. Bhat (Blackpool, Bolton, United Kingdom). Thromboprophylaxis in medical in-patients: are we there yet?. Eur Respir J 2007; 30: Suppl. 51, 629

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Smoking habits in hospitalized patients in a pulmonology department–what changed in six years?
Source: International Congress 2017 – Passive smoking and epidemiology
Year: 2017


Primary prophylaxis against venous thromboembolism in medical in-patients: audit of our practice in a large teaching hospital
Source: Eur Respir J 2006; 28: Suppl. 50, 45s
Year: 2006

Are patients ready for rehabilitation?
Source: Eur Respir J 2005; 26: Suppl. 49, 70s
Year: 2005

Initial outpatient management of PE: who and how?
Source: International Congress 2018 – Pulmonary embolism: what we need to know
Year: 2018


Oxygen therapy in acute medical admissions - are junior doctors getting it right?
Source: Eur Respir J 2005; 26: Suppl. 49, 523s
Year: 2005

Palliative care on non-oncologic patients in a pulmonology ward – a three year review
Source: Virtual Congress 2020 – Interesting clinical problems for the respiratory physician
Year: 2020


Pulmonary rehabilitation in the elderly patients in a medicine ward
Source: Annual Congress 2008 - Impact of rehabilitation programmes in COPD and non-COPD patients
Year: 2008


Audit on oxygen prescribing in medical wards: are we meeting hospital guidelines?
Source: Annual Congress 2004 - Emphysema and oxygen therapy
Year: 2004


Variance between clinical opinion and practice in the prescription of thromboprophylaxis for medical patients
Source: Annual Congress 2007 - Venous thromboembolism
Year: 2007


?ersonalized rehabilitation of COVID-19 patients in Russia: initial experience
Source: Virtual Congress 2021 – Pulmonary rehabilitation in the COVID-19 era
Year: 2021


Auditing thromboembolism prophylaxis in a district general hospital: A lean approach to improve practice
Source: Annual Congress 2010 - Pulmonary embolism
Year: 2010

Are COPD patients referred to palliative care?
Source: Annual Congress 2011 - Exacerbations and severe chronic respiratory disease: oxygen, rehabilitation, admission to hospital and palliative care
Year: 2011

Implementing venous thromboprophylaxis in medical patients: an opt out approach
Source: Annual Congress 2009 - Pulmonary embolism
Year: 2009


Rehabilitation in primary care: can we do it?
Source: Annual Congress 2008 - Integrated multidisciplinary care of COPD
Year: 2008


Assessment and management of asthma in the emergency department: are guidelines implemented?
Source: Eur Respir J 2001; 18: Suppl. 33, 51s
Year: 2001

Quality management in thoracic oncology: how do patients and clinicians benefit?
Source: Annual Congress 2012 - Good quality clinical recommendations for thoracic malignancy management in Europe
Year: 2012


Current practice in reducing perioperative and critical care pulmonary complications in obese patients: A review of London bariatric services
Source: International Congress 2016 – Dealing with the complexity of critically-ill patients
Year: 2016

E-learning course on COPD prevention for Russian GP: what do the doctors say?
Source: Annual Congress 2007 - Smoking and the lung
Year: 2007


Knowledge and misconceptions about inhalation therapy in pulmology: Patients vs. medical students
Source: Annual Congress 2010 - Treatment options for asthma
Year: 2010


Social care and discharge planning for COPD patients: lessons from the UK 2008 audit?
Source: Annual Congress 2009 - Organisation of care for individuals with chronic respiratory disease
Year: 2009